ArticlePloS one2017

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.

Navin Sarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.